Cellectis S.A. - CLLS

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$32.51M
QoQ value delta ($000)
-$18.53M (-36.3%)
Implied price effect (QoQ)
-34.49%
Shares
Total shares
10,256,218
QoQ shares delta
-291,842 (-2.77%)
Total shares held by funds (by quarter)

Market chart (CLLS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 32 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
B Group, Inc. 10,402 3,281,501 7.71%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 10,076 3,178,620 0.0%
Long Focus Capital Management, LLC 8,698 2,744,098 0.23%
BlackRock, Inc. 1,082 341,523 0.0%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 719 226,875 0.0%
MORGAN STANLEY 275 86,776 0.0%
LPL Financial LLC 267 84,345 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 209 65,942 0.0%
CITADEL ADVISORS LLC 140 44,315 0.0%
MARSHALL WACE, LLP 130 41,112 0.0%
BNP PARIBAS FINANCIAL MARKETS 129 41,000 0.0%
UBS Group AG 94 29,774 0.0%
Delaney Dennis R 76 24,000 0.03%
XTX Topco Ltd 51 16,269 0.0%
RHUMBLINE ADVISERS 47 15,085 0.0%
Global Retirement Partners, LLC 34 7,038 0.0%
Lido Advisors, LLC 31 10,094 0.0%
HARBOUR INVESTMENTS, INC. 14 4,500 0.0%
NATIONAL BANK OF CANADA /FI/ 11 3,600 0.0%
WELLS FARGO & COMPANY/MN 9 3,150 0.0%
Tower Research Capital LLC (TRC) 5 1,797 0.0%
Atlantic Union Bankshares Corp 4 1,500 0.0%
QUADRANT CAPITAL GROUP LLC 2 944 0.0%
GAMMA Investing LLC 2 734 0.0%
Allworth Financial LP 1 500 0.0%